Table III.
Variable | Odds Ratio | P-value | 95% CI | |
---|---|---|---|---|
Cytarabine | Courses Per Site | 1.026 | 0.007 | 1.007–1.045 |
Daunorubicin | Courses Per Site | 1.012 | 0.014 | 1.002–1.022 |
Etoposide | Courses Per Site | 1.042 | <0.001 | 1.021–1.062 |
Univariate logistic regression analyses were performed for demographic variables and the number of courses per hospital site. GEE method was used to account for clustering by hospital. Only the variables with statistically significant results for at least one chemotherapy medication are shown.